2026 Q3 Portfolio Activity
In 2026 Q3, Venrock Adviser, LLC maintained a portfolio of 40 distinct positions. The most significant new addition was KORSANA BIOSCIENCES INC, now representing 7.07% of the total fund value. They heavily accumulated shares in ERASCA INC, increasing the position by 12.3%. Conversely, Venrock Adviser, LLC completely exited their position in APOGEE THERAPEUTICS INC.
Position History
hover any row below to update
Loading…
Total Positions
40
Quarter
2026 Q3
Top Holding
ORKA (16.8%)
Top 10 Concentration
71.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-40 of 40
Venrock Adviser, LLC Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ORKA
ORUKA THERAPEUT...
|
Healthcare | 16.79% | 11.97% |
#1
1
Prev: #2
|
7.0 |
—
|
no change | no change |
P
S
|
4,148,428 | $345,522,568 |
$21.30
+365.9%
|
2024 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
ERAS
ERASCA INC
|
Healthcare | 14.31% | 9.94% |
#2
1
Prev: #3
|
7.5 |
—
|
2,198,120 | 12.3% |
P
S
|
20,089,932 | $294,518,403 |
$4.65
+198.9%
|
2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
SYRE
SPYRE THERAPEUT...
|
Healthcare | 10.75% | 8.04% |
#3
1
Prev: #4
|
5.5 |
—
|
-500,000 | -16.7% |
P
S
|
2,485,448 | $221,279,435 |
$24.68
+280.2%
|
2023 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
KRSA
KORSANA BIOSCIE...
|
Healthcare | 7.07% | — |
#4
Prev: #—
|
6.8 |
—
|
4,549,585 | — |
NEW
|
4,549,585 | $145,586,720 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SVRA
SAVARA INC
|
Healthcare | 4.91% | 2.75% |
#5
3
Prev: #8
|
5.0 |
—
|
4,822,591 | 32.7% |
P
S
|
19,568,534 | $100,973,635 | 2022 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
OCUL
OCULAR THERAPEU...
|
Healthcare | 3.86% | 3.08% |
#6
Prev: #6
|
2.5 |
—
|
no change | no change |
P
S
|
10,346,926 | $79,360,922 | 2023 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
N/A
DAMORA THERAPEU...
|
|
Unknown | 3.73% | — |
#7
Prev: #—
|
5.0 |
—
|
3,603,595 | — |
NEW
|
3,603,595 | $76,684,502 | — | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 3.52% | 3.49% |
#8
3
Prev: #5
|
1.4 |
—
|
-357,980 | -30.3% |
P
S
|
822,020 | $72,378,861 | 2023 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 3.26% | 1.81% |
#9
2
Prev: #11
|
2.3 |
—
|
no change | no change |
P
S
|
3,257,917 | $67,080,511 | 2020 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
VOR
VOR BIOPHARMA I...
|
Healthcare | 2.82% | 1.70% |
#10
2
Prev: #12
|
2.1 |
—
|
no change | no change |
P
S
|
3,041,719 | $58,035,999 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 2.55% | 1.93% |
#11
1
Prev: #10
|
2.0 |
—
|
no change | no change |
P
S
|
1,642,166 | $52,582,155 | 2020 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ANL
ADLAI NORTYE GR...
|
Healthcare | 2.50% | 1.12% |
#12
7
Prev: #19
|
2.0 |
—
|
no change | no change |
P
S
|
3,212,731 | $51,403,696 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
JBIO
JADE BIOSCIENCE...
|
Healthcare | 2.20% | 2.17% |
#13
4
Prev: #9
|
1.9 |
—
|
no change | no change |
P
S
|
3,220,364 | $45,246,114 | 2025 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ACHV
ACHIEVE LIFE SC...
|
Healthcare | 2.16% | 0.54% |
#14
12
Prev: #26
|
3.9 |
—
|
2,751,032 | 100.0% |
P
S
|
5,502,064 | $44,511,698 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MAZE
MAZE THERAPEUTI...
|
Healthcare | 2.04% | 1.45% |
#15
1
Prev: #14
|
1.3 |
—
|
-56,418 | -3.5% |
P
S
|
1,545,616 | $42,009,843 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ORIC
ORIC PHARMACEUT...
|
Healthcare | 1.93% | 1.42% |
#16
Prev: #16
|
0.8 |
—
|
-1,375,709 | -31.8% |
P
S
|
2,944,056 | $39,656,434 | 2023 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
DYN
DYNE THERAPEUTI...
|
Healthcare | 1.70% | 1.46% |
#17
4
Prev: #13
|
1.7 |
—
|
no change | no change |
P
S
|
2,173,913 | $35,021,738 | 2023 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ADRX
ADARX PHARMACEU...
|
Healthcare | 1.58% | — |
#18
Prev: #—
|
4.1 |
—
|
1,625,793 | — |
NEW
|
1,625,793 | $32,418,312 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
N/A
CRESCENT BIOPHA...
|
|
Unknown | 1.51% | 1.16% |
#19
2
Prev: #17
|
1.1 |
—
|
158 | 0.0% |
P
S
|
2,133,734 | $31,131,179 | — | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
RLMD
RELMADA THERAPE...
|
Healthcare | 1.36% | 1.44% |
#20
5
Prev: #15
|
2.5 |
—
|
600,745 | 8.8% |
P
S
|
7,445,050 | $28,067,839 | 2020 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ZURA
ZURA BIO LTD
|
Healthcare | 1.30% | 1.15% |
#21
3
Prev: #18
|
1.5 |
—
|
no change | no change |
P
S
|
6,434,990 | $26,769,558 | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
XFOR
X4 PHARMACEUTIC...
|
Healthcare | 1.08% | 0.27% |
#22
9
Prev: #31
|
3.4 |
—
|
5,709,819 | 295.2% |
P
S
|
7,644,072 | $22,167,809 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CGEM
CULLINAN THERAP...
|
Healthcare | 1.03% | 0.76% |
#23
1
Prev: #22
|
1.4 |
—
|
no change | no change |
P
S
|
1,379,965 | $21,182,463 | 2021 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SRZN
SURROZEN INC
|
Healthcare | 0.99% | 0.50% |
#24
4
Prev: #28
|
1.4 |
—
|
no change | no change |
P
S
|
632,931 | $20,367,720 | 2025 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PBLS
PARABILIS MEDIC...
|
Healthcare | 0.98% | 0.52% |
#25
2
Prev: #27
|
1.4 |
—
|
no change | no change |
P
S
|
625,000 | $20,181,250 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ARVN
ARVINAS INC
|
Healthcare | 0.73% | — |
#26
Prev: #—
|
3.8 |
—
|
1,952,533 | — |
NEW
|
1,952,533 | $15,102,843 | 2023 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IPSC
CENTURY THERAPE...
|
Healthcare | 0.72% | 0.65% |
#27
4
Prev: #23
|
1.3 |
—
|
no change | no change |
P
S
|
8,695,652 | $14,869,565 | 2024 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ENTX
ENTERA BIO LTD
|
Healthcare | 0.72% | — |
#28
Prev: #—
|
3.8 |
—
|
5,106,337 | — |
NEW
|
5,106,337 | $14,859,441 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ARTV
ARTIVA BIOTHERA...
|
Healthcare | 0.71% | 0.60% |
#29
5
Prev: #24
|
1.3 |
—
|
no change | no change |
P
S
|
2,043,596 | $14,550,404 | 2024 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ANRO
ALTO NEUROSCIEN...
|
Healthcare | 0.62% | 0.40% |
#30
Prev: #30
|
1.2 |
—
|
no change | no change |
P
S
|
500,000 | $12,765,000 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
KRRO
KORRO BIO INC
|
Healthcare | 0.21% | 0.40% |
#31
2
Prev: #29
|
0.1 |
—
|
-566,069 | -56.1% |
P
S
|
443,431 | $4,394,401 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
N/A
TCGX ACQUISITIO...
|
|
Unknown | 0.18% | — |
#32
Prev: #—
|
3.6 |
—
|
300,000 | — |
NEW
|
300,000 | $3,753,000 | — | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
N/A
RESEARCH ALLIAN...
|
|
Unknown | 0.17% | — |
#33
Prev: #—
|
3.6 |
—
|
300,000 | — |
NEW
|
300,000 | $3,600,000 | — | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
INM
INMED PHARMACEU...
|
Healthcare | 0.01% | 0.00% |
#34
1
Prev: #33
|
3.0 |
—
|
100,693 | 308.1% |
P
S
|
133,378 | $181,394 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
N/A
RESEARCH ALLIAN...
|
|
Unknown | 0.00% | 0.10% |
Sold All 😨
(Was: #32) |
0.0 |
—
|
-300,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
CTMX
CYTOMX THERAPEU...
|
Healthcare | 0.00% | 0.57% |
Sold All 😨
(Was: #25) |
0.0 |
—
|
-4,982,124 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CYBN
CYBIN INC
|
Unknown | 0.00% | 0.77% |
Sold All 😨
(Was: #21) |
0.0 |
—
|
-3,851,654 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ELVN
ENLIVEN THERAPE...
|
Healthcare | 0.00% | 0.81% |
Sold All 😨
(Was: #20) |
0.0 |
—
|
-526,331 | -100.0% |
CLOSED
|
— | $— | 2023 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
GLTO
DAMORA THERAPEU...
|
Healthcare | 0.00% | 2.84% |
Sold All 😨
(Was: #7) |
0.0 |
—
|
-3,603,595 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
APGE
APOGEE THERAPEU...
|
Healthcare | 0.00% | 34.18% |
Sold All 😨
(Was: #1) |
0.0 |
—
|
-8,493,321 | -100.0% |
CLOSED
|
— | $— | 2023 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 |
Showing 1-40 of 40 holdings